Renal Insufficiency, Chronic D051436

Related MeSH Hierarchy (4)

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Kidney Diseases » Renal Insufficiency » Renal Insufficiency, Chronic

Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Kidney Diseases » Renal Insufficiency » Renal Insufficiency, Chronic

Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Disease Attributes » Chronic Disease » Renal Insufficiency, Chronic

Description

Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)   MeSH

Subtype Terms (1)

Kidney Failure, Chronic
560 drugs (310 approved, 250 experimental)


Phase 4 Indicated Drugs (134)


Organization Involved with Phase 4 Indications (213)

Gilead Sciences

Government of China

Government of Mexico

Hanmi Pharmaceutical

Harvard University

Heilongjiang University of Traditional Chinese Medicine

Henry Ford Health System

Hexal AG

Hospital Aleman

Hospital General de México Dr. Eduardo Liceaga

Hospital General de Zona N° 83 Instituto Mexicano del Seguro Social.

Hospital General Regional N° 1 Instituto Mexicano del Seguro Social.

Hospital General Universitario Gregorio Marañon

Huazhong University of Science and Technology

Hue University

I.M. Sechenov First Moscow State Medical University

INC Research

Indiana University

Inje University

Institute for Health Outcomes and Process Evaluation Reseach

Ironwood Pharmaceuticals

Janssen Pharmaceutica NV

Jemincare

Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.

Jiao Tong University

Jichi Medical University

Jilin University

Johnson and Johnson

Keryx

Kitasato University

Korea University

Kureha Corporation

KVT-Study Group

Kyung Hee University

Kyushu University

Lakehead University

Laval University

LinkDoc Technology (Beijing) Co. Ltd.

Mackay Medical College

Maisonneuve-Rosemont Hospital

Maria Eugenia Galván Plata

McGill University

McMaster University

Medical Research Council

Medical Research Foundation, The Netherlands

Medical University of Gdansk

Medical University of Lodz

Medpace, Inc.

Merck

Monash University

Nanjing Medical University

National Cheng Kung University

National Health and Medical Research Council, Australia

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Organization Involved with Phase 3 Indications (171)

Organization Involved with Phase 2 Indications (86)

Organization Involved with Other Experimental Indications (61)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.